{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-005421","form_type":"8-K","ticker":"NTHI","cik":"0001979414","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","filed_at":"2026-05-18T21:00:15+00:00","discovered_at":"2026-05-18T21:02:00.392328+00:00","generated_at":"2026-05-18T21:09:07.160252+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeOnc reports Q1 net loss $8.8M; NEO212 Phase 1 complete, NEO100 interim data Aug 2026","bullets":["Net loss $8.8M ($0.38/diluted) vs $32.3M ($1.78) in Q1 2025; G&A down to $489K, R&D up to $1.29M.","Cash $138,601 at Mar 31; $10M PIPE from Cinctive Capital and $10M undrawn credit line fund ops into Sep 2026.","NEO212 Phase 1 complete, RP2D set at 610 mg; FDA End-of-Phase 1 meeting planned for potential registrational Phase 2.","NEO100 Phase 2a fully enrolled in IDH1-mutant high-grade glioma; interim data readout expected August 2026.","Appointed David Choi as CAO; CEO Amir Heshmatpour purchased >$500k of NTHI shares in open market."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005421","json":"https://secwatch.observer/filing/0001829126-26-005421.json","markdown":"https://secwatch.observer/filing/0001829126-26-005421.md","text":"https://secwatch.observer/filing/0001829126-26-005421.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979414/000182912626005421/0001829126-26-005421-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979414/000182912626005421/neonctechnologies_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T21:09:07.160252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"425f25dabe1c82dbbab503e3d49750a35bc06714","claim":"NEONC TECHNOLOGIES HOLDINGS, INC. reported first quarter ended March 31, 2026 results: net income $8.8 million or $(0.38) per diluted share, EPS $(0.38) per diluted share.","evidence_excerpt":"NeOnc Provides Business Update and Reports Q1 2026 Financial Results","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1979414/000182912626005421/0001829126-26-005421-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Net income","value":"$8.8 million or $(0.38) per diluted share"},{"label":"EPS","value":"$(0.38) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}